Turkey's coronavirus candidate vaccines pass animal tests
Turkey has stepped up its vaccine production ability, with three Turkish firms boasting the capacity to produce 160 million doses of vaccines, the Turkish industry and technology minister said on Thursday.
FOUR CANDIDATES COMPLETE ANIMAL TRIALS
"Four Turkish-made coronavirus candidate vaccines have completed animal trials successfully," Mustafa Varank told an online medicine and vaccine conference organized by Turkey’s Scientific and Technological Research Council’s (TUBITAK) Coronavirus Platform.
In Turkey, 1.9 million cases have been seen since March, while the virus caused around 17,000 deaths.
The Coronavirus Turkey Platform used many different global vaccine technologies, employing even more innovative techniques, said Varank.
Varank said a vaccine and medicine developing center will be established within one year as part of TUBITAK.